Evidence map›Paper›PMID 31391888›Full record

ArticleMedChemComm2019

Nodulisporic acid E biosynthesis:

Kyle C Van de Bittner, Rosannah C Cameron, Leyla Y Bustamante, Rudranuj Bundela, Sarah A Kessans, Jan Vorster, Matthew J Nicholson, Emily J Parker

Open access · bronzeAbstract read
In one paragraph

Article in MedChemComm, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kyle C Van de BittnerFerrier Research Institute , Victoria University of Wellington , Kelburn , Wellington 6012 , New Zealand . Email: matthew.nicholson@vuw.ac.nz ; Email: Emily.parker@vuw.ac.nz.ORCID 0000-0002-3810-2227
Rosannah C CameronFerrier Research Institute , Victoria University of Wellington , Kelburn , Wellington 6012 , New Zealand . Email: matthew.nicholson@vuw.ac.nz ; Email: Emily.parker@vuw.ac.nz.
Leyla Y BustamanteFerrier Research Institute , Victoria University of Wellington , Kelburn , Wellington 6012 , New Zealand . Email: matthew.nicholson@vuw.ac.nz ; Email: Emily.parker@vuw.ac.nz.
Rudranuj BundelaFerrier Research Institute , Victoria University of Wellington , Kelburn , Wellington 6012 , New Zealand . Email: matthew.nicholson@vuw.ac.nz ; Email: Emily.parker@vuw.ac.nz.
Sarah A KessansBiomolecular Interaction Centre and School of Biological Sciences , University of Canterbury , PO Box 4800 , Christchurch 8140 , New Zealand.ORCID 0000-0003-1136-5577
Jan VorsterSchool of Chemical and Physical Sciences , Victoria University of Wellington , PO Box 6012 , Wellington , New Zealand.
Matthew J NicholsonFerrier Research Institute , Victoria University of Wellington , Kelburn , Wellington 6012 , New Zealand . Email: matthew.nicholson@vuw.ac.nz ; Email: Emily.parker@vuw.ac.nz.
Emily J ParkerFerrier Research Institute , Victoria University of Wellington , Kelburn , Wellington 6012 , New Zealand . Email: matthew.nicholson@vuw.ac.nz ; Email: Emily.parker@vuw.ac.nz.ORCID 0000-0002-9571-9987
Victoria University of Wellington · NZUniversity of Canterbury · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prenylation of aromatic compounds is a key tailoring reaction in biosynthesis of bioactive indole-diterpenes. Here, we identify NodD1 as the enzyme responsible for the bisprenylation of nodulisporic acid F. This prenyltransferase showed a preference for its natural indole-diterpene substrate whereas other related enzymes were not able to catalyse this conversion.

Identifiers

PMID31391888
PMCPMC6640557
OpenAlexW2947558382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.